Children with childhood leukemia benefit from prophylactic antibiotics

Prophylactic antibiotics significantly reduce the risk of serious bacterial infections in children during the critical first month of treatment for acute lymphoblastic leukemia (ALL), the most common childhood cancer, according to a US and Canadian study. While the overall cure rate for ALL is high, about one to two percent of children with this diagnosis die during the first month of therapy from treatment complications, primarily infection-related.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1NDXYLa